NCT00062049View on ClinicalTrials.gov

Interleukin-7 in Treating Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

May 31, 2011

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

recombinant interleukin-7

Trial Locations (3)

20892

NCI - Center for Cancer Research, Bethesda

77030

Methodist Hospital, Houston

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00062049 - Interleukin-7 in Treating Patients With Refractory Solid Tumors | Biotech Hunter | Biotech Hunter